The key challenge would be ensuring that the vaccine is received by those who need it most, namely disadvantaged communities who have suffered worse outcomes from the COVID-19 "syndemic." The action would be ensuring that policy makers at EU and national level consider health equity as a key factor in decision-making around prioritisation of early doses of COVID-19 vaccine.